Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F D Goebel

Showing results (201-210 of 239) with videos related to

Pageof 24
Sort By:
AIDS (London, England)|January 1, 1994
Conjunctival microvasculopathy and Kaposi's sarcoma in patients with AIDSS Baumann, S A Geier, E Thoma-Gerber, et al.
Klinische Wochenschrift|June 1, 1989
[Cryptococcus neoformans meningoencephalitis and multiple infections in AIDS]W G Zoller, H Kellner, F D Goebel, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Pharmacokinetics of zidovudine after rectal administration in human immunodeficiency virus-infected patientsU Wintergerst, B Rolinski, J R Bogner, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 10, 2001
Alterations of apolipoprotein B metabolism in HIV-infected patients with antiretroviral combination therapyM Schmitz, G M Michl, R Walli, et al.
AIDS (London, England)|May 1, 1993
Retinal microvascular abnormalities in patients with AIDS-related complex or lymphadenopathy syndromeS A Geier, K Holler, J Nasemann, et al.
Der Nervenarzt|February 1, 1989
[Psychiatric symptoms and neuropsychologic manifestations in HIV-infected patients]D Naber, C Perro, U Schick, et al.
Klinische Wochenschrift|April 17, 1989
Treatment of secretory diarrhea in AIDS with the somatostatin analogue SMS 201-995H S Füessl, W G Zoller, M M Kochen, et al.
Antiviral Therapy|May 1, 2001
Phase I/II trial with fozivudine tidoxil (BM 21.1290): a 7 day randomized, placebo-controlled dose-escalating trialJ R Bogner, M Roecken, D B Herrmann, et al.
Gene Therapy|June 11, 2010
MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assaysS Kutscher, S Allgayer, C J Dembek, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|July 17, 1998
HIV-1-infected long-term slow progressors heterozygous for delta32-CCR5 show significantly lower plasma viral load than wild-type slow progressorsR Walli, B Reinhart, B Luckow, et al.
Pageof 24

Showing results (201-210 of 239) with videos related to

Sort By:
Pageof 24
AIDS (London, England)|January 1, 1994
Conjunctival microvasculopathy and Kaposi's sarcoma in patients with AIDSS Baumann, S A Geier, E Thoma-Gerber, et al.
Klinische Wochenschrift|June 1, 1989
[Cryptococcus neoformans meningoencephalitis and multiple infections in AIDS]W G Zoller, H Kellner, F D Goebel, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Pharmacokinetics of zidovudine after rectal administration in human immunodeficiency virus-infected patientsU Wintergerst, B Rolinski, J R Bogner, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 10, 2001
Alterations of apolipoprotein B metabolism in HIV-infected patients with antiretroviral combination therapyM Schmitz, G M Michl, R Walli, et al.
AIDS (London, England)|May 1, 1993
Retinal microvascular abnormalities in patients with AIDS-related complex or lymphadenopathy syndromeS A Geier, K Holler, J Nasemann, et al.
Der Nervenarzt|February 1, 1989
[Psychiatric symptoms and neuropsychologic manifestations in HIV-infected patients]D Naber, C Perro, U Schick, et al.
Klinische Wochenschrift|April 17, 1989
Treatment of secretory diarrhea in AIDS with the somatostatin analogue SMS 201-995H S Füessl, W G Zoller, M M Kochen, et al.
Antiviral Therapy|May 1, 2001
Phase I/II trial with fozivudine tidoxil (BM 21.1290): a 7 day randomized, placebo-controlled dose-escalating trialJ R Bogner, M Roecken, D B Herrmann, et al.
Gene Therapy|June 11, 2010
MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assaysS Kutscher, S Allgayer, C J Dembek, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|July 17, 1998
HIV-1-infected long-term slow progressors heterozygous for delta32-CCR5 show significantly lower plasma viral load than wild-type slow progressorsR Walli, B Reinhart, B Luckow, et al.
Pageof 24